The latest news, stories and exciting findings from across the Oxford cancer research community
28 July 2021
New research from Ross Chapman’s lab has discovered the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.
27 July 2021
Our new brand represents how Oxford researchers are working across disciplines to translate their discoveries into better care for cancer patients. Meet the new brand and the people behind it.
26 July 2021
A new artificial intelligence software that will help doctors to make quicker and more accurate decisions when diagnosing potentially cancerous lung lesions, has received major government funding.
16 July 2021
A new study from the Newstead group at the Department of Biochemistry has solved the structure of the human folate transporter, paving the way for improved anticancer drugs.
14 July 2021
A new pan-divisional initiative has launched at the University of Oxford. Bringing together the collective force of cancer research, outreach and care that happen across the city of Oxford.
6 July 2021
Botnar Research Centre researchers have developed standalone long-read sequencing of single cells technology that could open new avenues into the causes of diseases like cancer.
5 July 2021
Professor Stefan Constantinescu joins Ludwig Oxford to expand his research programme in cancer epigenetics.
2 July 2021
University of Oxford researchers have begun recruitment to a study looking at whether chemotherapy medication can reach pancreatic tumours more effectively if encapsulated within a heat-sensitive shell and triggered with focused ultrasound.
1 July 2021
The awardees from the 2021 round of the CRUK Oxford Centre Development fund have been announced. Read about what research they will be undertaking.
24 June 2021
A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by Paige, will be investigated in a multicentre clinical study led by Oxford University.
22 June 2021
Congratulations to Dr Karthik Ramasamy & Dr John Jacob on their CARP awards from the Medical Research Council. Find more about their work that is being funded.
21 June 2021
A recent collaborative study from the University of Oxford has investigated the potential benefit of a combined therapy approach to prostate cancer treatment, using radiotherapy and vascular targeted photodynamic therapy (VTP), which could lead to first-in-man early phase clinical trials.
18 June 2021
A multidisciplinary team of researchers based in Oxford, Tanzania and Uganda are testing novel diagnostic tools and strengthening local capacity to improve early diagnosis of blood cancers called lymphomas, common diseases in children and young adults in sub-Saharan Africa
17 June 2021
Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.
9 June 2021
Clinicians and engineers in Oxford have begun using artificial intelligence alongside endoscopy to get more accurate readings of the pre-cancerous condition Barrett’s oesophagus and so determine patients most at risk of developing cancer.
8 June 2021
Principal Investigator Tim Maughan talks about the forward-thinking approach of the FOCUS4 cancer clinical trials and how they have helped shape the UK's fight against COVID-19
4 June 2021
Using her new CRUK Oxford Centre Development Fund award, Dr Linna Zhou will investigate the role of the nervous system in cancer progression using engineered gastrointestinal tissues.
1 June 2021
As part of UK Pride month, we are spotlighting the work of cancer researcher and University LGBTQ+ Representative Dr Eoghan Mulholland
26 May 2021
A multidisciplinary team in Oxford has developed an algorithm for automated requesting of additional investigation in diagnostically uncertain prostate biopsies.
25 May 2021
Oxford is delighted to welcome this acclaimed scientist to the Ludwig Oxford community.